Quick Answer
Phathom Pharmaceuticals, Inc. reported Research And Development Expense of $32.78 million for the year ending 2025.
- Phathom Pharmaceuticals, Inc. showed a decrease of -3.8% in Research And Development Expense from 2024 to 2025.
- This data is from Phathom Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 8 years of available data (2018 to 2025), Phathom Pharmaceuticals, Inc.'s Research And Development Expense has grown by 163,800.0%.
- Historical annual values: Fiscal year 2025: $32.78 million | Fiscal year 2024: $34.08 million | Fiscal year 2023: $49.90 million | Fiscal year 2022: $71.44 million | Fiscal year 2021: $72.34 million | Fiscal year 2020: $98.15 million | Fiscal year 2019: $20.37 million | Fiscal year 2018: $20.0 thousand.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: